What are the current results of sutureless valves in high-risk aortic valve disease patients?

Interactive Cardiovascular and Thoracic Surgery

Volumn 14, Issue 5, 2012, Pages 615-621

  Sepehripour, Amir H ^a   Harling, Leanne ^b   Athanasiou, Thanos ^b  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Aortic valve; Aortic valve replacement; Sutureless valve

Indexed keywords

AORTA CLAMPING; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL PROTOCOL; ENDOCARDITIS; FOLLOW UP; FUNCTIONAL STATUS; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; INCIDENCE; KIDNEY FAILURE; MITRAL VALVE REGURGITATION; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; STROKE; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SUTURELESS AORTIC VALVE; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BENCHMARKING; EVIDENCE-BASED MEDICINE; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SUTURE TECHNIQUES; TREATMENT OUTCOME;

EID: 84863482987     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs011     Document Type: Article

References (8)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-9.
2. Smith C, Leon M, Mack M, Miller D, Moses J, Svensson L et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
3. Martens S, Sadowski J, Eckstein F, Bartus K, Kapelak B, Sievers H et al. Clinical experience with the ATS 3f Enable sutureless bioprosthesis. Eur J Cardiothorac Surg 2011;40:749-55.
4. Flameng W, Herregods M, Hermans H, Van der Mieren G, Vercalsteren M, Poortmans G et al. Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on intraoperative and early post-operative outcomes. J Thorac Cardiovasc Surg 2011;142:1453-7.
5. Breitenbach I, Wimmer-Greinecker G, Bockeria L, Sadowski J, Schmitz C, Kapelak B et al. Sutureless aortic valve replacement with the Trilogy Aortic Valve System: multicentre experience. J Thorac Cardiovasc Surg 2010;140:878-84.
6. Aymard T, Kadner A, Walpoth N, Gober V, Englberger L, Stalder M et al. Clinical experience with the second-generation 3f Enable sutureless aortic valve prosthesis. J Thorac Cardiovasc Surg 2010;140: 313-6.
7. Martens S, Ploss A, Sirat S, Miskovic A, Moritz A, Doss M. Sutureless aortic valve replacement with the 3f Enable aortic bioprosthesis. Ann Thorac Surg 2009;87:1914-8.
8. Shrestha M, Folliguet T, Meuris B, Dibie A, Bara C, Herregods M et al. Sutureless Perceval S aortic valve replacement: a multicentre prospective pilot trial. J Heart Valve Dis 2009;18:698-702.